LB presents preclinical data ‘supporting’ LB-102’s mechanism of actionLB Pharmaceuticals (LBRX) announced the presentation of four posters at the 39th European College of Neuropsychopharmacology Congress, taking pl...Markets Insider7d agoWhole story →Education